Pressreleases

Celebrating being winners of the Golden Bridge Trade & Export Awards 2015

We are thrilled to be winners of the Golden Bridge Trade & Export Awards 2015 in the Best British Medium-sized Company category.

RWS Acquires Leading Life Sciences Translation Company

Corporate Translations Inc (CTi), the world's leading life sciences translation and linguistic validation provider, has been acquired by RWS, the world's leading provider of intellectual property support services.

Johnson Matthey Acquires Pharmaceutical Manufacturing Capacity in Scotland, UK

Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has announced completion of an acquisition of pharmaceutical manufacturing capacity in Scotland, U.K. The 109,000 sq. metre site was acquired to meet increasing demand for custom pharmaceutical services and active ingredients utilising enhanced manufacturing capabilities.

Johnson Matthey Commissions New High Containment Manufacturing Capacity in Edinburgh, UK

Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has announced completion and commissioning of new high containment facilities for potent product manufacture at its Edinburgh, UK site (Macfarlan Smith).

Johnson Matthey Rebrands its Fine Chemicals Division

Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has today unveiled the distinctive new branding for its Fine Chemicals Division. The new brand brings together Johnson Matthey’s broad chiral and catalysis technologies, its world-leading opiates and narcotics capabilities, and global API development, life cycle management and manufacturing expertise.

Johnson Matthey Receives Two Pharmaceutical and Biotech CMO Leaderships Awards 2015

Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has been recognised in the 2015 CMO Leadership Awards for the Reliability and Regulatory Track record of its Pharma Services to the Biotech Industry.

Johnson Matthey Acquires Pharmorphix

Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has acquired the Pharmorphix® solid form research business from Sigma-Aldrich. This acquisition brings world-leading material science capabilities to Johnson Matthey’s expanding European API and clinical supply services.

Latest News

Dr. Hans-Jürgen Rieger of Molnár-Institute gave a short lecture at the Eastern Analytical Symposium in Somerset, NJ last month. The talk focused on modeling of HPLC method robustness

MRN Adds 11 More in Transatlantic Expansion

Medical Research Network (MRN), the market leader in global home healthcare for clinical trials, has expanded further with a raft of new hires in the UK and US.